TNF and COVID-19: GSDME was also shown to be cleaved in PBMCs of healthy donors after treatment with a combination of TNF-α and IFNγ, two cytokines linked to COVID-19 severity [26], further indicating a potential role of GSDME as a backup mechanism for cell death during SARS-CoV-2 infection.